Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay.
about
Identifying Recent HIV Infections: From Serological Assays to GenomicsMolecular and phylogeographic analysis of human immuno-deficiency virus type 1 strains infecting treatment-naive patients from Kigali, RwandaInter-laboratory assessment of a prototype multiplex kit for determination of recent HIV-1 infectionDetection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studiesHigh burden of prevalent and recently acquired HIV among female sex workers and female HIV voluntary testing center clients in Kigali, RwandaCharacterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs.Low proportion of recent human immunodeficiency virus (HIV) infections among newly diagnosed cases of HIV infection as shown by the presence of HIV-specific antibodies of low avidity.Performance characteristics of an antibody-based multiplex kit for determining recent HIV-1 infection.Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infectionThe infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012-2014.Dual testing algorithm of BED-CEIA and AxSYM Avidity Index assays performs best in identifying recent HIV infection in a sample of Rwandan sex workersMixture models for calibrating the BED for HIV incidence testing.Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots.The potential role of biomarkers in HIV preventive vaccine trialsHIV incidence estimate combining HIV/AIDS surveillance, testing history information and HIV test to identify recent infections in Lazio, Italy.Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infectionHigh percentage of recent HIV infection among HIV-positive individuals newly diagnosed at voluntary counseling and testing sites in Poland.Evaluation of a multiplex assay for estimation of HIV-1 incidence.Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypesAvidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassaysSerum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins.Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes.Sample size methods for estimating HIV incidence from cross-sectional surveys.Decreased specificity of an assay for recent infection in HIV-1-infected patients on highly active antiretroviral treatment: implications for incidence estimates.HIV incidence among non-pregnant women living in selected rural, semi-rural and urban areas in KwaZulu-Natal, South Africa.Risk Factor Detection as a Metric of STARHS Performance for HIV Incidence Surveillance Among Female Sex Workers in Kigali, RwandaEstimating the distribution of the window period for recent HIV infections: a comparison of statistical methods.Comparison of the human immunodeficiency virus (HIV) type 1-specific immunoglobulin G capture enzyme-linked immunosorbent assay and the avidity index method for identification of recent HIV infections.Current and future assays for identifying recent HIV infections at the population levelCross-sectional HIV incidence estimation in HIV prevention research.Immunoassays for the diagnosis of HIV: meeting future needs by enhancing the quality of testing.Estimates of HIV-1 incidence based on serological methods: a brief methodological review.HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy.MSM in Bogotá are living with HIV for extended periods without diagnosis or treatment.Evaluation of the limiting antigen avidity EIA (LAg) in people who inject drugs in Greece.Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections.Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.HIV-1 envelope sequence-based diversity measures for identifying recent infections.The Recent Infection Testing Algorithm (RITA) in clinical practice: a survey of HIV clinicians in England and Northern Ireland.
P2860
Q26778001-80BAC310-994B-4956-AF3C-D3FD74B405FAQ28482242-FC6B1A61-2259-4AE1-9CAA-FC9F7D92153EQ28534491-42749E9A-CEDC-416D-A048-0B7D2BFD009FQ28730904-F4E12E7F-84D8-4104-BB49-92A007F2459CQ28744694-2292FF8A-7191-41F2-8090-29C787DC3576Q33483060-DA421A52-F640-4FEC-9EF9-743BE050BCA8Q33592734-7339774F-112C-4A14-A9CE-25DD068E9CBBQ33637675-6420FC7E-098D-464A-994C-95DA69B18D1CQ33767397-C5F0AD03-96E6-4061-A5CA-C1F1EB6B3924Q33806894-06432074-C621-4424-9C58-6CDE5098833AQ33885838-8F16A3AC-C887-4C11-B187-662A6565C7F6Q33924641-F8C47DF4-D38D-4B9E-B3C8-29E886BB99ABQ34042316-8DBDF8CF-9BA1-46FB-952A-E48AF73985BCQ34059957-76904FA6-69C1-409C-8B64-8AB6C7BB3CB6Q34203609-9A84073B-914F-4D10-A384-8FB78B4B52D9Q34214893-DA6B6E72-2C6D-491E-B810-626EACA6205EQ34647528-9643C9A8-60E8-4062-B435-AF5A05FA43C6Q34745421-C31F7E47-B98C-43AE-B7C6-1154DC3BFD58Q35119643-B9AE8F46-5D3D-4751-8BC6-915FC2E12F3DQ35140064-F4EF99A8-7CD1-47F4-A96D-142687A36D7BQ35165681-ECE17F6C-6659-4F76-90A2-EBA4C9651CFEQ35690562-CA4E12AE-9C34-43C7-854F-E5B3247EB4D2Q35753750-2A34B92B-B75A-452D-B66A-480E71F9F173Q36154647-B42011C4-8E40-4431-B3B3-B22F603AEB09Q36279405-D272D298-3805-4D31-992F-EE1EC2513862Q36302106-9676A998-8F45-4F8A-A799-9868CAE0139DQ36316124-64F2FC0B-77DB-4B27-936F-52B49829667BQ36423630-8C5EA1FB-CE74-4C8E-AECD-5FEBB51A9D30Q36516631-9ED1486E-EFE3-4A94-BB89-C24A749FC83FQ37080530-56DBA854-FEB7-480D-BAC4-11DBBF2D1BFCQ37613666-75BA844B-B43C-4586-AFDE-D3DE1DD498ACQ37866660-87B6E54C-F466-4CBE-96CA-FBF52038480DQ38390465-4B7656B6-6A0F-48DC-A53B-3434A75D1261Q40441518-AD95C4CA-0C12-41BC-B2E2-0B2694464F53Q40485453-B9E5D0A0-4B1A-481A-8C4C-BC3FF1B78BFDQ40710284-174F35BA-F881-4A0D-9EDD-62E5E8E1C4E4Q40751062-EF2B6DD0-385C-40A6-AF14-28D34D2FC337Q48336460-31D2B787-E8FF-4A1F-BEEC-49C89991312FQ50586645-6051165D-77E3-4BAD-A45D-80C5AA66167E
P2860
Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Identifying recent HIV infecti ...... automated enzyme immunoassay.
@en
Identifying recent HIV infecti ...... automated enzyme immunoassay.
@nl
type
label
Identifying recent HIV infecti ...... automated enzyme immunoassay.
@en
Identifying recent HIV infecti ...... automated enzyme immunoassay.
@nl
prefLabel
Identifying recent HIV infecti ...... automated enzyme immunoassay.
@en
Identifying recent HIV infecti ...... automated enzyme immunoassay.
@nl
P2093
P1476
Identifying recent HIV infecti ...... automated enzyme immunoassay.
@en
P2093
Alessandro Sinicco
Barbara Suligoi
Claudio Galli
Fiorella Di Sora
Francesco Montella
Mario Massi
Mauro Sciandra
Olga Recchia
P304
P356
10.1097/00126334-200304010-00012
P407
P577
2003-04-01T00:00:00Z